-
St. Jude gene therapy cures babies with 'bubble boy' disease
04/17/2019
Novel combination gene therapy pioneered at St. Jude cures "bubble boy" disease and provides template for treating other genetic disorders. Read about the landmark study.
-
St. Jude Children’s Research Hospital and the World Federation of Hemophilia announce collaboration
04/17/2019
Collaboration will improve the understanding of how advanced technologies, such as gene therapy for hemophilia B, can move rapidly to countries with limited resources.
-
St. Jude Children’s Research Hospital Named Health Non-Profit Brand of the Year for 6th consecutive year
04/15/2019
For the sixth consecutive year, St. Jude has been named the Health Non-Profit Brand of the Year based on the 2019 Harris Poll EquiTrend® Equity Score.
-
Research reveals how the most common ALS mutation dooms cells
04/10/2019
Toxic DPRs disrupt cell function in ALS, much like uninvited dinner party guests, and displace binding partners that help maintain normal nucleolus and ribosome assembly.
-
Biochemical switches identified that could be triggered to treat muscle, brain disorders
04/10/2019
Enzymes ULK1 and ULK2 play a key role in breaking down cell structures called stress granules, whose persistence leads to toxic buildup of proteins that kill muscle and brain cells
-
St. Jude Children's Research Hospital selected as a finalist in Fast Company magazine's World Changing Ideas Awards
04/09/2019
The recognition was earned for sharing several decades worth of genetic cancer data and a five-year collaboration with World Health Organization.
-
St. Jude at AACR 2019
04/02/2019
Explore research and resources by St. Jude at the 2019 Annual Meeting of the American Association for Cancer Research (AACR) in Atlanta.
-
AACR: Genetic study identifies a risk factor for stroke among cancer survivors
04/02/2019
This investigation draws on whole genome sequencing and other data gathered longitudinally through the St. Jude Lifetime Cohort (SJLIFE) study.
-
Inherited genetic variation linked to risk of T cell leukemia in children
04/01/2019
The study identified a novel variant of the USP7 gene as playing a role in increasing the risk of developing T-ALL. The inherited genetic variant is linked to lower expression of USP7.
-
AACR highlights and honors St. Jude research from the laboratory to the clinic
03/29/2019
Research ranges on a variety of topics such as survivorship, clinical genomics, deep sequencing, disease models and the biology of pediatric cancers.
-
Genomic analysis offers roadmap for diagnosis and treatment of a high-risk leukemia
03/29/2019
Genomic analysis reveals the biology of acute erythroid leukemia, a rare cancer with few survivors
-
American Association for Cancer Research honors Cancer Control and Survivorship Program
03/28/2019
The St. Jude Cancer Control and Survivorship Program is a multidisciplinary research program which strives to improve the quality of life of individuals surviving childhood cancer.
-
St. Jude strengthens collaboration to improve pediatric cancer care in Asia
03/26/2019
The agreement reflects the St. Jude commitment to transform pediatric cancer care in low- to moderate-income nations that are home to 90 percent of childhood cancer patients.
-
Researchers develop method to dramatically reduce error rate in next-generation sequencing
03/13/2019
Check out what happens when math and biology combine to tackle error rates in next-generation DNA sequencing. The answer is good news for cancer patients.
-
American Society of Clinical Oncology honors St. Jude president and CEO
03/13/2019
Downing will discuss our understanding of the molecular landscape of childhood cancer, which can benefit cancer patients of all ages and raise global cancer cure rates.
-
Genomic testing of a single patient reveals a gene commonly mutated in pediatric melanoma
03/04/2019
Comprehensive clinical genomic testing proves its worth; leads to discovery of a mutation that drives the most common childhood melanoma.
-
Radiation after surgery triples survival for a type of pediatric brain tumor
03/01/2019
Cooperative clinical trial gives immediate postoperative radiation for children under age 3 with ependymoma, illustrates effectiveness of postoperative radiation.
-
Genetic variations in a fourth gene linked to elevated leukemia risk in Hispanic children
02/14/2019
Progress reported on understanding why Hispanic children are more likely to develop acute lymphoblastic leukemia and to die of the disease.
-
St. Jude Children’s Research Hospital named to Fortune magazine’s “100 Best Companies to Work For’ for ninth consecutive year
02/14/2019
The institution is the highest-ranked Memphis-based organization; for nearly a decade, Fortune has recognized the hospital’s commitment to employee
-
St. Jude Children’s Research Hospital honored as recipient of the 2019 Microsoft Health Innovation Awards
02/13/2019
St. Jude Children’s Research Hospital announced it has been named a recipient of Microsoft Corp.’s 2019 Health Innovation Awards.
-
Customized drug interaction alerts address alert fatigue, protect patients
02/13/2019
Researchers developed a method for customizing and reducing drug interaction alerts in electronic health records for pediatric cancer patients.
-
St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences launches Master of Science degree program
02/04/2019
New program will integrate traditional training and experiential learning at St. Jude campus and partner site.
-
St. Jude researchers discover key genomic 'management' partners in brain development
02/04/2019
The study reports how two unexpected partners, the proteins UTX and 53BP1, link up to regulate a brain development program comprising hundreds of genes.
-
St. Jude collaboration offers research road map to improve pediatric patient care
01/23/2019
Survey results should help health system leaders and patient safety experts dedicate resources to improve safety and clinical outcomes in pediatric health care.
-
No substantial benefit from transplantation reported for a high-risk leukemia subtype
01/18/2019
Children with hypodiploid acute lymphoblastic leukemia fare better when minimal residual disease is used to guide treatment.
-
More accurate leukemia diagnosis expected as researchers refine leukemia classification
01/14/2019
Research led by St. Jude Children's Research Hospital means more than 90 percent of the most common cases of childhood cancer can now be classified by subtype, an advance likely to fuel precision medicine.
-
Research reveals machinery of a deadly childhood brain cancer
12/27/2018
Investigators studied the effects of the H3 K27M mutation, and revealed its impact on mutations that are known drivers of DIPGs.
-
Newly identified subset of immune cells may be key to fighting chronic inflammation
12/20/2018
Read about the newly identified subset of helper T 17 immune cells that suggest a novel approach for taming chronic inflammation.
-
St. Jude Children’s Research Hospital announces first-of-its-kind partnership with global esports organization Immortals
12/18/2018
Global Esports organization, Immortals, haspartnered with St. Jude to raise $500,000 to help children battling cancer and other life-threatening diseases..
-
AbbVie donates $50 million to St. Jude to expand family-centered care
12/06/2018
The largest one-time gift in the history of St. Jude will fund the new Family Commons, a treatment-free floor for patients and their families.
